OneOncology has filed a notice of an exempt offering of securities to raise $75,186,787.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, OneOncology is raising $75,186,787.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Jeffrey Patton played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About OneOncology
OneOncology is a partnership of independent community oncology practices committed to driving the future of cancer care delivery through a patient-centric, physician-driven, and technology-powered model to help improve the lives of everyone living with cancer. OneOncology empowers community oncology practices by supporting the entire continuum of care, including prevention and diagnosis, research and treatment, and long-term survivorship, palliative, and hospice care. Our technology provides access to key clinical and operational data and the latest research via a cloud-based network. This comprehensive approach supports community oncologists transition to value-based care and commitment to providing their patients with access to best-in-class healthcare, close to home. For OneOncology, cancer is personal, and the mission is critical. Working together with world class oncologists, OneOncology looks to drive the change that community cancer needs through continual learning, creative and smart evolution, and a collective desire to positively impact the lives of every person touched by cancer.
To learn more about OneOncology, visit http://www.oneoncology.com/
Contact:
Jeffrey Patton, Chief Executive Officer
615-880-8467
https://www.linkedin.com/in/jeffrey-patton-39a9a45/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.